Atlas FDA

OLC

3 FDA 510(k) clearances · Product code

FDA profile

Official device name
Scaffold, Partial Medial Meniscal Defects Extending Into The Red/White Zone, Resorbable Bovine Collagen
Device class
Class II (moderate risk)
Regulation
21 CFR 878.3300
Medical specialty
General, Plastic Surgery
Flags
Implant
FDA definition
Intended for use in surgical procedures for the repair and reinforcement of soft tissue injuries of the medial meniscus. In repairing and reinforcing medial meniscal defects, the patient must have an intact meniscal rim and anterior and posterior horns for attachment of the mesh. In addition, the surgically prepared site must extend at least into the red/white zone of the meniscus to provide sufficient vascularization. The device reinforces soft tissue and provides a resorbable scaffold that is replaced by the patients own soft tissue. The device is not a prosthetic device and is not intended to replace normal body structure.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
RejuvaKnee™ Collagen Meniscus Implant (K242302)Collagen Matrix, Inc.2024-10-02
Collagen Meniscus Implant XL (K170364)Ivy Sports Medicine, LLC2017-05-02
REGEN COLLAGEN SCAFFOLD (CS) (K082079)Regen Biologics, Inc.2008-12-18

Track OLC automatically

Every clearance here is in the API, with alerts when new ones post.